Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma

Abstract Background We aimed to build a novel model with golgi apparatus related genes (GaGs) signature and relevant clinical parameters for predicting progression-free interval (PFI) after surgery for papillary thyroid carcinoma (PTC). Methods We performed a bioinformatic analysis of integrated PTC...

Full description

Bibliographic Details
Main Authors: Rui Liu, Zhen Cao, Mengwei Wu, Xiaobin Li, Peizhi Fan, Ziwen Liu
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Medical Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12920-023-01485-z
_version_ 1797853501477355520
author Rui Liu
Zhen Cao
Mengwei Wu
Xiaobin Li
Peizhi Fan
Ziwen Liu
author_facet Rui Liu
Zhen Cao
Mengwei Wu
Xiaobin Li
Peizhi Fan
Ziwen Liu
author_sort Rui Liu
collection DOAJ
description Abstract Background We aimed to build a novel model with golgi apparatus related genes (GaGs) signature and relevant clinical parameters for predicting progression-free interval (PFI) after surgery for papillary thyroid carcinoma (PTC). Methods We performed a bioinformatic analysis of integrated PTC datasets with the GaGs to identify differentially expressed GaGs (DE-GaGs). Then we generated PFI-related DE-GaGs and established a novel GaGs based signature. After that, we validated the signature on multiple external datasets and PTC cell lines. Further, we conducted uni- and multivariate analyses to identify independent prognostic characters. Finally, we established a signature and clinical parameters-based nomogram for predicting the PFI of PTC. Results We identified 260 DE-GaGs related to PFI in PTC. The functional enrichment analysis showed that the DE-MTGs were associated with an essential oncogenic glycoprotein biosynthetic process. Consequently, we established and optimized a novel 11 gene signature that could distinguish patients with poorer prognoses and predicted PFI accurately. The novel signature had a C-index of 0.78, and the relevant nomogram had a C-index of 0.79. Also, it was closely related to the pivotal clinical characters of and anaplastic potential in datasets and PTC cell lines. And the signature was confirmed a significant independent prognostic factor in PTC. Finally, we built a nomogram by including the signature and relevant clinical factors. Validation analysis showed that the nomogram’s efficacy was satisfying in predicting PTC’s PFI. Conclusion The GaGs signature and nomogram were closely associated with PTC prognosis and may help clinicians improve the individualized prediction of PFI, especially for high-risk patients after surgery.
first_indexed 2024-04-09T19:51:38Z
format Article
id doaj.art-27e521039db549b49f394ae66a50270a
institution Directory Open Access Journal
issn 1755-8794
language English
last_indexed 2024-04-09T19:51:38Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj.art-27e521039db549b49f394ae66a50270a2023-04-03T05:43:51ZengBMCBMC Medical Genomics1755-87942023-03-0116111410.1186/s12920-023-01485-zGolgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinomaRui Liu0Zhen Cao1Mengwei Wu2Xiaobin Li3Peizhi Fan4Ziwen Liu5Department of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital/The First Affiliated Hospital of Hunan Normal UniversityDepartment of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Breast and Thyroid Surgery, Hunan Provincial People’s Hospital/The First Affiliated Hospital of Hunan Normal UniversityDepartment of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Background We aimed to build a novel model with golgi apparatus related genes (GaGs) signature and relevant clinical parameters for predicting progression-free interval (PFI) after surgery for papillary thyroid carcinoma (PTC). Methods We performed a bioinformatic analysis of integrated PTC datasets with the GaGs to identify differentially expressed GaGs (DE-GaGs). Then we generated PFI-related DE-GaGs and established a novel GaGs based signature. After that, we validated the signature on multiple external datasets and PTC cell lines. Further, we conducted uni- and multivariate analyses to identify independent prognostic characters. Finally, we established a signature and clinical parameters-based nomogram for predicting the PFI of PTC. Results We identified 260 DE-GaGs related to PFI in PTC. The functional enrichment analysis showed that the DE-MTGs were associated with an essential oncogenic glycoprotein biosynthetic process. Consequently, we established and optimized a novel 11 gene signature that could distinguish patients with poorer prognoses and predicted PFI accurately. The novel signature had a C-index of 0.78, and the relevant nomogram had a C-index of 0.79. Also, it was closely related to the pivotal clinical characters of and anaplastic potential in datasets and PTC cell lines. And the signature was confirmed a significant independent prognostic factor in PTC. Finally, we built a nomogram by including the signature and relevant clinical factors. Validation analysis showed that the nomogram’s efficacy was satisfying in predicting PTC’s PFI. Conclusion The GaGs signature and nomogram were closely associated with PTC prognosis and may help clinicians improve the individualized prediction of PFI, especially for high-risk patients after surgery.https://doi.org/10.1186/s12920-023-01485-zPapillary thyroid carcinomaPredictive modelThe Cancer Genome Atlas ProgramGolgi apparatus related genesNomogram
spellingShingle Rui Liu
Zhen Cao
Mengwei Wu
Xiaobin Li
Peizhi Fan
Ziwen Liu
Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
BMC Medical Genomics
Papillary thyroid carcinoma
Predictive model
The Cancer Genome Atlas Program
Golgi apparatus related genes
Nomogram
title Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
title_full Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
title_fullStr Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
title_full_unstemmed Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
title_short Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma
title_sort golgi apparatus genes related signature for predicting the progression free interval of patients with papillary thyroid carcinoma
topic Papillary thyroid carcinoma
Predictive model
The Cancer Genome Atlas Program
Golgi apparatus related genes
Nomogram
url https://doi.org/10.1186/s12920-023-01485-z
work_keys_str_mv AT ruiliu golgiapparatusgenesrelatedsignatureforpredictingtheprogressionfreeintervalofpatientswithpapillarythyroidcarcinoma
AT zhencao golgiapparatusgenesrelatedsignatureforpredictingtheprogressionfreeintervalofpatientswithpapillarythyroidcarcinoma
AT mengweiwu golgiapparatusgenesrelatedsignatureforpredictingtheprogressionfreeintervalofpatientswithpapillarythyroidcarcinoma
AT xiaobinli golgiapparatusgenesrelatedsignatureforpredictingtheprogressionfreeintervalofpatientswithpapillarythyroidcarcinoma
AT peizhifan golgiapparatusgenesrelatedsignatureforpredictingtheprogressionfreeintervalofpatientswithpapillarythyroidcarcinoma
AT ziwenliu golgiapparatusgenesrelatedsignatureforpredictingtheprogressionfreeintervalofpatientswithpapillarythyroidcarcinoma